Zevra Therapeutics, Inc. (ZVRA)
8.12
-0.05
(-0.61%)
USD |
NASDAQ |
Dec 16, 16:00
8.12
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Research and Development Expense (Annual): 35.71M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 119.64M |
| XOMA Royalty Corp. | 2.875M |
| Akebia Therapeutics, Inc. | 31.99M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |